G1 Therapeutics
- Pharmaceutical Preparations
- Research Triangle Park, North Carolina
Compensation history
Top executives at G1 Therapeutics received an average of $2M per person in annual compensation from 2016 to 2022.
By year
- 2020
MV$4MMark A. VellecaFormer Chief Executive Officer and PresidentSG$3MSoma GuptaChief Commercial OfficerJM$2MJennifer K. MosesChief Financial OfficerMA$1MMark AvaglianoChief Business OfficerRM$1MRajesh K. MalikChief Medical OfficerJB$758KJohn E. Bailey, JrCurrent Chief Executive Officer and President
Executives
We found ten executives who work or worked at G1 Therapeutics.
John Bailey
G1 Therapeutics
Chief Executive Officer
Jennifer Moses
G1 Therapeutics
Chief Financial Officer
Mark Avagliano
G1 Therapeutics
Chief Business Officer
Mark Velleca
G1 Therapeutics
Chief Executive Officer
Rajesh Malik
G1 Therapeutics
Chief Medical Officer
Soma Gupta
G1 Therapeutics
Chief Commercial Officer
John Demaree
G1 Therapeutics
Chief Commercial Officer
Barclay Phillips
G1 Therapeutics
Chief Financial Officer
News
G1 Therapeutics CEO John Bailey's 2022 pay falls 65% to $3M
April 26, 2023
G1 Therapeutics CEO Mark Velleca's 2020 pay stays at $4M
April 28, 2021
G1 Therapeutics Chief Business Officer Mark Avagliano receives $5.5M in 2019
April 24, 2020
G1 Therapeutics Chief Commercial Officer John Demaree receives $7.5M in 2018
April 30, 2019
About G1 Therapeutics
- Industry classifications
- Manufacturing
- Chemicals And Allied Products
- Drugs
- Pharmaceutical Preparations
- 700 Park Offices Drive, Suite 200, Research Triangle Park, North Carolina 27709
- 919-213-9835
- December 31
- Former names
- G-Zero Therapeutics, Inc.